They demonstrated that expression of ERβ was significantly downregulated in HCC tissue compared with normal liver tissue; moreover, ERβ expression had a significant negative correlation with disease progression and a positive correlation with the expression level of NLRP3 inflammasome components. The gene discussed is ESR2; the disease is hepatocellular carcinoma.